Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Beyond rodent models of pain: non-human primate models for evaluating novel analgesic therapeutics and elaborating pain mechanisms.

Hama AT, Toide K, Takamatsu H.

CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1257-70. Review.

PMID:
24111837
2.

Nrf2 deficiency leads to behavioral, neurochemical and transcriptional changes in mice.

Muramatsu H, Katsuoka F, Toide K, Shimizu Y, Furusako S, Yamamoto M.

Genes Cells. 2013 Oct;18(10):899-908. doi: 10.1111/gtc.12083. Epub 2013 Jul 29.

3.

Studies on somnolence in the daytime caused by drugs used for neuropathic pain.

Takeda Y, Ishida T, Tsutsui R, Toide K, Tanimoto-Mori S, Watanabe S, Kanai Y, Kamei C.

J Pharmacol Sci. 2008 Jul;107(3):246-50. Epub 2008 Jun 28.

4.

Synergy between a NR2B receptor antagonist DHQ and 3-methyl-gabapentin in mice with neuropathic pain.

Imai A, Hizue M, Toide K.

Eur J Pharmacol. 2008 Jul 7;588(2-3):244-7. doi: 10.1016/j.ejphar.2008.04.033. Epub 2008 May 29.

PMID:
18511033
6.

Pharmacologic investigation of the mechanism underlying cold allodynia using a new cold plate procedure in rats with chronic constriction injuries.

Tanimoto-Mori S, Nakazato-Imasato E, Toide K, Kita Y.

Behav Pharmacol. 2008 Feb;19(1):85-90. doi: 10.1097/FBP.0b013e3282f3d0a3.

PMID:
18195599
7.
8.

Changes of sleep patterns in rats with chronic constriction injury under aversive conditions.

Tokunaga S, Takeda Y, Shinomiya K, Yamamoto W, Utsu Y, Toide K, Kamei C.

Biol Pharm Bull. 2007 Nov;30(11):2088-90.

9.

[Basic research on analgesics: basis of pain and novel pain targets].

Toide K.

Nihon Yakurigaku Zasshi. 2006 Nov;128(5):321-5. Review. Japanese. No abstract available.

PMID:
17102577
10.

A major genotype in UDP-glucuronosyltransferase 2B15.

Toide K, Umeda S, Yamazaki H, Takahashi Y, Terauchi Y, Fujii T, Kamataki T.

Drug Metab Pharmacokinet. 2002;17(2):164-6.

11.
12.
13.

Hepatocyte nuclear factor-1alpha is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers.

Toide K, Takahashi Y, Yamazaki H, Terauchi Y, Fujii T, Parkinson A, Kamataki T.

Drug Metab Dispos. 2002 Jun;30(6):613-5.

PMID:
12019184
14.

Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.

Mori T, Takase H, Toide K, Hirano T, Kambe T, Nakayama N, Schwartz A.

Cardiovasc Drug Rev. 2001 Spring;19(1):1-8. Review.

PMID:
11314598
15.

A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation.

Ariyoshi N, Miyazaki M, Toide K, Sawamura Yi, Kamataki T.

Biochem Biophys Res Commun. 2001 Mar;281(5):1256-60.

PMID:
11243870
16.

Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator.

Hirano T, Mori T, Kido M, Toide K, Ohura M, Fujiki H, Orito K, Yoshida K, Ikezono K, Sumida T, Nakayama N, Yabuuchi Y.

Fundam Clin Pharmacol. 1999;13(6):650-5.

PMID:
10626752
18.

Identification of possible quantitative trait loci responsible for hyperglycaemia after 70% pancreatectomy using a spontaneously diabetogenic rat.

Ogino T, Moralejo DH, Zhu M, Toide K, Wei S, Wei K, Yamada T, Mizuno A, Matsumoto K, Shima K.

Genet Res. 1999 Feb;73(1):29-36.

PMID:
10218444
19.

Identification of a quantitative trait locus influencing plasma insulin levels after 70% pancreatectomy using the OLETF rat.

Moralejo DH, Ogino T, Zhu M, Toide K, Wei S, Wei K, Yamada T, Mizuno A, Matsumoto K, Shima K.

J Vet Med Sci. 1998 Oct;60(10):1157-60.

20.

A major quantitative trait locus co-localizing with cholecystokinin type A receptor gene influences poor pancreatic proliferation in a spontaneously diabetogenic rat.

Moralejo DH, Ogino T, Zhu M, Toide K, Wei S, Wei K, Yamada T, Mizuno A, Matsumoto K, Shima K.

Mamm Genome. 1998 Oct;9(10):794-8.

PMID:
9745032
21.
22.

Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain.

Toide K, Man ZW, Asahi Y, Sato T, Nakayama N, Noma Y, Oka Y, Shima K.

Diabetes Res Clin Pract. 1997 Dec;38(3):151-60.

PMID:
9483380
23.

Effect of a prolyl endopeptidase inhibitor, JTP-4819, on radial maze performance in hippocampal-lesioned rats.

Miyazaki A, Toide K, Sasaki Y, Ichitani Y, Iwasaki T.

Pharmacol Biochem Behav. 1998 Feb;59(2):361-8.

PMID:
9476982
24.

Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation.

Kuriyama H, Yamashita S, Shimomura I, Funahashi T, Ishigami M, Aragane K, Miyaoka K, Nakamura T, Takemura K, Man Z, Toide K, Nakayama N, Fukuda Y, Lin MC, Wetterau JR, Matsuzawa Y.

Hepatology. 1998 Feb;27(2):557-62.

PMID:
9462657
25.

Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM.

Man ZW, Zhu M, Noma Y, Toide K, Sato T, Asahi Y, Hirashima T, Mori S, Kawano K, Mizuno A, Sano T, Shima K.

Diabetes. 1997 Nov;46(11):1718-24.

PMID:
9356017
26.

Specific inhibitor for prolyl endopeptidase suppresses the generation of amyloid beta protein in NG108-15 cells.

Shinoda M, Toide K, Ohsawa I, Kohsaka S.

Biochem Biophys Res Commun. 1997 Jun 27;235(3):641-5.

PMID:
9207212
28.

Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats.

Toide K, Shinoda M, Fujiwara T, Iwamoto Y.

Pharmacol Biochem Behav. 1997 Mar;56(3):427-34.

PMID:
9077579
29.

A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease.

Toide K, Shinoda M, Iwamoto Y, Fujiwara T, Okamiya K, Uemura A.

Behav Brain Res. 1997 Feb;83(1-2):147-51.

PMID:
9062674
30.

Gene structure of mouse Cyp3a11: evidence for an enhancer element within its 5' flanking sequences.

Toide K, Itoh S, Nagasaka Y, Yanagimoto T, Kamataki T.

Arch Biochem Biophys. 1997 Feb 1;338(1):43-9.

PMID:
9015386
31.

Application of primary hepatocytes from p53-knockout mice for studies of expression of Cyp3a.

Shimoji M, Itoh S, Toide K, Nakayama K, Aizawa S, Kamataki T.

J Biochem. 1996 Jul;120(1):42-8.

32.
33.

Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.

Toide K, Fujiwara T, Iwamoto Y, Shinoda M, Okamiya K, Kato T.

Naunyn Schmiedebergs Arch Pharmacol. 1996 Feb;353(3):355-62.

PMID:
8692293
35.

Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM.

Sato T, Asahi Y, Toide K, Nakayama N.

Diabetologia. 1995 Sep;38(9):1033-41.

PMID:
8591816
36.

JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer.

Toide K, Iwamoto Y, Fujiwara T, Abe H.

J Pharmacol Exp Ther. 1995 Sep;274(3):1370-8.

PMID:
7562510
38.

Effect of JTP-2942, a novel thyrotropin-releasing hormone analogue, on pentobarbital-induced anesthesia in rats.

Matsushita M, Yonemori F, Hamada A, Toide K, Iwata K.

Eur J Pharmacol. 1995 Mar 24;276(1-2):177-82.

PMID:
7781687
39.

Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control.

Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T.

Eur J Biochem. 1993 Dec 1;218(2):585-95.

40.
41.
42.
44.

[Behavioral pharmacological properties of propiverine hydrochloride (P-4) in mice and rats].

Toide K, Murakami H, Miyake H.

Yakubutsu Seishin Kodo. 1989 Jun;9(2):233-40. Japanese.

PMID:
2816096
45.
47.
49.

Effects of 5-Fluorouracil prodrugs on the central nervous system in mice and rats.

Toide K, Unemi N, Segawa T.

Pharm Res. 1985 Mar;2(2):83-6. doi: 10.1023/A:1016394829072.

PMID:
24272616

Supplemental Content

Support Center